A clinical experience with Gengraf™ (Abbott cyclosporine) in de novo renal transplant recipients.

被引：0
|
作者：
Scandling, J
Rajagopalan, PR
Magee, J
Conti, D
Mendez, R
Bronson, D
Awni, W
Nabulsi, A
Hoffman, R
机构：
[1] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
[2] Med Univ S Carolina, Charleston, SC 29425 USA
[3] Univ Michigan, Med Ctr, Ann Arbor, MI USA
[4] Albany Med Coll, Albany, NY 12208 USA
[5] Natl Inst Transplantat, Los Angeles, CA USA
[6] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
TRANSPLANTATION | 2000年 / 69卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
184
引用
收藏
页码：S161 / S161
页数：1
相关论文
共 50 条
  • [41] Fibromyalgia and Its Clinical Relevance in Renal Transplant Recipients.
    Uyar, M. Erkmen
    Sezer, S.
    Bal, Z.
    Guliyev, O.
    Tutal, E.
    Demirci, B. Gurlek
    Haberal, M.
    TRANSPLANTATION, 2014, 98 : 573 - 573
  • [42] Analysis of cyclosporine associated arteriolopathy in long-term cyclosporine treated renal transplant recipients.
    Ishii, D
    Tanabe, K
    Ishida, H
    Miyamoto, N
    Ishikawa, N
    Tokumoto, T
    Shirakawa, H
    Shimizu, T
    Shimmura, H
    Setoguchi, K
    Toki, D
    Toma, H
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 555 - 555
  • [43] Evolution of the absorption profile of cyclosporine A in renal transplant recipients:: a longitudinal study of the de novo and maintenance phases
    Büchler, M
    Chadban, S
    Cole, E
    Midtvedt, K
    Thervet, E
    Prestele, H
    Keown, P
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (01) : 197 - 202
  • [44] Clinical experience with repeated courses of thymoglobulin for induction and for treatment of rejection in renal transplant recipients.
    Lo, A
    Olson, B
    Gaber, LW
    Gaber, AO
    PHARMACOTHERAPY, 2003, 23 (03): : 413 - 413
  • [45] Economic evaluation of everolimus with reduced-dose cyclosporine in de novo renal transplant recipients in Hungary
    Kósa, J
    Yang, X
    Kiss, É
    Kaló, Z
    VALUE IN HEALTH, 2005, 8 (06) : A78 - A79
  • [46] Tuberculosis in renal transplant recipients.
    Koselj, M
    Bren, A
    Kandus, A
    SternSkralovnik, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3437 - A3437
  • [47] Tuberculosis in renal transplant recipients.
    Almeida, RV
    Carvalho, JGR
    Mulinari, RA
    Hauck, P
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3295 - A3295
  • [48] De Novo Visceral Malignancies in Renal Transplant Recipients: Single Center Experience of 2119 Renal Transplantations
    Zavos, G.
    Moris, D.
    Vernadakis, S.
    Kostakis, I.
    Bokos, J.
    Boletis, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 244 - 244
  • [49] De Novo Visceral Malignancies in Renal Transplant Recipients: Single Center Experience of 2119 Renal Transplantations
    Zavos, G.
    Moris, D.
    Vernadakis, S.
    Kostakis, I.
    Bokos, J.
    Boletis, J.
    TRANSPLANTATION, 2014, 98 : 244 - 244
  • [50] The effect of cyclosporine on serum lipids and the susceptibility of LDL to oxidation in renal transplant recipients.
    Young, IS
    McKeown, A
    Hasselwander, O
    McEneny, J
    Lightbody, JH
    Loughrey, CM
    Fogarty, D
    Maxwell, AP
    Nicholls, DP
    ATHEROSCLEROSIS, 1997, 128 (02) : 17 - 17
12345